WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that the Company’s President and Chief Executive Officer, Noah D. Beerman, will present a corporate overview at the ROTH 22nd Annual OC Growth Stock Conference on Wednesday, March 17, 2010 at 10:00 a.m. PT. This annual three-day conference will be held March 15-17 at the Ritz Carlton Laguna Niguel in Dana Point, CA.
